chr11-62338033-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000415229.6(ASRGL1):c.56G>A(p.Arg19Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000112 in 1,608,304 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R19L) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000415229.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASRGL1 | NM_001083926.2 | c.56G>A | p.Arg19Gln | missense_variant | 2/7 | ENST00000415229.6 | NP_001077395.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASRGL1 | ENST00000415229.6 | c.56G>A | p.Arg19Gln | missense_variant | 2/7 | 1 | NM_001083926.2 | ENSP00000400057 | P1 | |
ENST00000400902.4 | n.58C>T | non_coding_transcript_exon_variant | 1/2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152240Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.00000421 AC: 1AN: 237558Hom.: 0 AF XY: 0.00000775 AC XY: 1AN XY: 128990
GnomAD4 exome AF: 0.00000481 AC: 7AN: 1455946Hom.: 0 Cov.: 32 AF XY: 0.00000553 AC XY: 4AN XY: 723782
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152358Hom.: 0 Cov.: 34 AF XY: 0.0000805 AC XY: 6AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2023 | The c.56G>A (p.R19Q) alteration is located in exon 2 (coding exon 1) of the ASRGL1 gene. This alteration results from a G to A substitution at nucleotide position 56, causing the arginine (R) at amino acid position 19 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 17, 2022 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 19 of the ASRGL1 protein (p.Arg19Gln). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with ASRGL1-related conditions. ClinVar contains an entry for this variant (Variation ID: 969179). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at